Ying‐Nai Wang

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis”.

The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis

Journal of Biomedical Science(2020)10.1186/s12929-020-00670-x

N/A

5.4DataRank · unranked

197 citations

Heng‐Huan Lee, Jennifer L. Hsu, Dihua Yu, Mien‐Chie Hung, Ying‐Nai Wang

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.101817

N/A

0.815DataRank · unranked

21 citations

Li-Chuan Chan, Ying‐Nai Wang, Yu‐Yi Chu, Chie‐Hong Wang, Heng‐Huan Lee +17 more

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02206-x

N/A

0.327DataRank · unranked

6 citations

Chunxiao Liu, Meisi Yan, Cong Chen, Yu Cheng, Yaohui Chen +20 more

Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex

Nature Cancer(2022)10.1038/s43018-022-00438-2

N/A

0DataRank · unranked

37 citations

Mei‐Kuang Chen, Yongkun Wei, Heng‐Huan Lee, Weiya Xia, Ying‐Nai Wang +21 more

An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic response

STAR Protocols(2022)10.1016/j.xpro.2022.101198

N/A

0DataRank · unranked

9 citations

Heng‐Huan Lee, Yongkun Wei, Yu‐Yi Chu, Weiya Xia, Michael Wang +3 more

Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation

International Journal of Biological Sciences(2023)10.7150/ijbs.84592

N/A

0DataRank · unranked

38 citations

Heng‐Huan Lee, Zhou Jiang, Li-Chuan Chan, Gabriel N. Hortobágyi, Dihua Yu +2 more

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

Blood(2025)10.1182/blood.2024026919

N/A

0DataRank · unranked

7 citations

Qingsong Cai, Yang Liu, Lei Nie, Heng‐Huan Lee, Fangfang Yan +24 more

FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models

Journal of Clinical Investigation(2025)10.1172/jci173757

N/A

0DataRank · unranked

4 citations

Hirohito Yamaguchi, Yuan Gao, Weiya Xia, Jeffrey T. Chang, Yu‐Chun Hsiao +27 more

Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma

Journal of Hepatology(2020)10.1016/j.jhep.2020.09.030

N/A

0DataRank · unranked

32 citations

Zhengyu Zha, Chenhao Zhou, Yeh Chen, Weiya Xia, Ying‐Nai Wang +14 more

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation

Nature Communications(2021)10.1038/s41467-021-23075-2

N/A

0DataRank · unranked

31 citations

Ying‐Nai Wang, Wenhao Yang, Weiya Xia, Yongkun Wei, Li-Chuan Chan +25 more